| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/30/2014 | WO2013149111A3 Anti-tlr4 antibodies and uses thereof |
| 01/30/2014 | US20140033337 Methods of Modifying Eukaryotic Cells |
| 01/30/2014 | US20140033336 Methods of Modifying Eukaryotic Cells |
| 01/30/2014 | US20140033335 Immunoglobulin 2 |
| 01/30/2014 | US20140032186 Systems and methods for antibody engineering |
| 01/30/2014 | US20140031529 Monoclonal antibody and a method thereof |
| 01/30/2014 | US20140031528 Method for selecting plasma cells or plasmablasts, method for producing target antigen specific antibodies, and novel monoclonal antibodies |
| 01/30/2014 | US20140031247 Methods and compositions for gamma-secretase assay |
| 01/30/2014 | US20140030761 Method of cloning nucleic acid |
| 01/30/2014 | US20140030758 Recombinant polypeptide production method |
| 01/30/2014 | US20140030731 Regents for probing rocks activation |
| 01/30/2014 | US20140030319 Antagonists Of The Oncongenic Activity Of The Protein MDM2, And Use Thereof In the Treatment of Cancers |
| 01/30/2014 | US20140030273 Human antibodies and antibody-drug conjugates against cd74 |
| 01/30/2014 | US20140030272 Methods for Diagnosing and Treating Iron Dysregulation |
| 01/30/2014 | US20140030271 Hmgb1 specific monoclonal antibodies |
| 01/30/2014 | US20140030270 Methods of treating or preventing cholesterol related disorders |
| 01/30/2014 | US20140030269 Staphylococcus aureus Specific Human Recombinant Polyclonal Antibodies and Uses Thereof |
| 01/30/2014 | US20140030267 Compositions, methods and kits relating to resistin |
| 01/30/2014 | US20140030265 Modified soluble fgf receptor fc fusions method |
| 01/30/2014 | US20140030264 Vaccines directed to langerhans cells |
| 01/30/2014 | US20140030263 Treatment of diffuse large-cell lymphoma with anti-cd20 antibody |
| 01/30/2014 | US20140030253 HUMANIZED FORMS OF MONOCLONAL ANTIBODIES TO HUMAN GnRH RECEPTOR |
| 01/30/2014 | US20140030252 Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
| 01/30/2014 | US20140030222 Recombinant fusion interferon for animals |
| 01/30/2014 | CA2875391A1 Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia |
| 01/29/2014 | EP2690113A1 Monoclonal antibodies that recognize progenitor cells |
| 01/29/2014 | EP2690112A1 Monoclonal antibodies that recognize progenitor cells |
| 01/29/2014 | EP2690111A1 Anti-mouse aggrus monoclonal antibody |
| 01/29/2014 | EP2689787A1 Identification and enrichment of cell subpopulations |
| 01/29/2014 | EP2689010A1 Method and compositions for cellular immunotherapy |
| 01/29/2014 | EP2688910A1 Anti - sclerostin antibody crystals and formulations thereof |
| 01/29/2014 | EP2688909A2 Hetero-dimeric immunoglobulins |
| 01/29/2014 | EP2688592A1 Compositions and methods to immunize against hepatitis c virus |
| 01/29/2014 | EP2688591A1 Dendritic cells (dcs) targeting for tuberculosis (tb) vaccine |
| 01/29/2014 | EP2344537B1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 01/29/2014 | EP2041180B1 Ilt3 binding molecules and uses therefor |
| 01/29/2014 | EP2006683B1 Human megalin determination method |
| 01/29/2014 | CN103547923A Biomarker for breast cancer |
| 01/29/2014 | CN103547598A Combination therapies comprising anti-ERBB 3 agents |
| 01/29/2014 | CN103547597A Novel modulators and methods of use |
| 01/29/2014 | CN103547596A Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of b-cell malignancies symptoms |
| 01/29/2014 | CN103547595A Humanised anti CTLA-4 antibodies |
| 01/29/2014 | CN103547594A Anti-notch1 antibodies |
| 01/29/2014 | CN103547593A Antibody, kit and method for determining amyloid peptides |
| 01/29/2014 | CN103547592A Methods of treating immune disorders with single domain antibodies against TNF-alpha |
| 01/29/2014 | CN103547288A Stem cell factor inhibitor |
| 01/29/2014 | CN103540600A Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 01/29/2014 | CN103539859A Self-assembled polypeptide nanometer for preparing contraception vaccine |
| 01/29/2014 | CN103539858A Connective tissue growth factor antibodies |
| 01/29/2014 | CN103539857A Antibodies against amyloid-beta peptide |
| 01/29/2014 | CN103539856A Preparation, detection and application of polyclonal antibody of Yam mild mosaic virus |
| 01/29/2014 | CN103539853A Specific antibody for resisting atrazine herbicide |
| 01/29/2014 | CN103539842A Recombinant protein coded by grass carp reovirus (GCRV) type-II S10 gene, polyclonal antibody prepared from recombinant protein and application of recombinant protein |
| 01/29/2014 | CN103539839A Neutralizing epitope peptide of enterovirus 71-type VP2 antigen and application thereof |
| 01/29/2014 | CN103536916A Methods for treating tweak-related conditions |
| 01/29/2014 | CN102746382B B-cell epitope peptide of heart fatty acid binding protein (H-FABP), antibody and applications thereof |
| 01/29/2014 | CN102603891B Method for preparing tetanus human immune globulin by double virus inactivation |
| 01/29/2014 | CN102584984B Artificially synthesized cinnamaldehyde complete antigen and application thereof |
| 01/29/2014 | CN102559602B Monoclonal antibody hybridoma cell line for secreting southern rice black-streaked dwarf resistant viruses and monoclonal antibody application thereof |
| 01/29/2014 | CN102295702B Preparation method of specific single-chain antibody aimed at T cell receptor variable range |
| 01/29/2014 | CN101583626B Anti-CD20 antibodies and methods of use |
| 01/29/2014 | CN101541833B Il-17 receptor a antigen binding proteins |
| 01/29/2014 | CN101400406B Compositions and methods of use for antibodies of dickkopf-1 and/or -4 |
| 01/28/2014 | US8637646 Growth hormone variants |
| 01/28/2014 | US8637645 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance |
| 01/28/2014 | US8637644 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance |
| 01/28/2014 | US8637643 Sclerostin binding antibody |
| 01/28/2014 | US8637642 Antibody drug conjugates (ADC) that bind to 191P4D12 proteins |
| 01/28/2014 | US8637641 Antibodies with modified isoelectric points |
| 01/28/2014 | US8637638 Method and composition for altering a B cell mediated pathology |
| 01/28/2014 | US8637635 Peptides that selectively home to heart vasculature and related conjugates and methods |
| 01/28/2014 | US8637456 Engineered polypeptide agents for targeted broad spectrum influenza neutralization |
| 01/28/2014 | US8637307 Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool |
| 01/28/2014 | US8637262 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| 01/28/2014 | US8637258 Compositions and methods for regulating NK cell activity |
| 01/28/2014 | US8637234 Molecular scaffolds for HIV-1 epitopes |
| 01/28/2014 | US8637037 Allergens and allergoids from bee venom |
| 01/28/2014 | US8637034 Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein |
| 01/28/2014 | US8637032 Antagonist anti-CD40 monoclonal antibodies and methods for their use |
| 01/28/2014 | US8637030 Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract |
| 01/28/2014 | US8637029 Methods for the treatment of gout |
| 01/28/2014 | US8637027 Anti c-Met antibodies |
| 01/28/2014 | US8637025 Composition and method for the treatment and prevention of enteric bacterial infections |
| 01/28/2014 | US8637015 Methods of antagonizing signal transduction in dorsal root ganglion cells |
| 01/28/2014 | US8637012 Genetic products differentially expressed in tumors and the use thereof |
| 01/28/2014 | US8636997 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist |
| 01/28/2014 | CA2662613C Compositions and methods relating to glucagon receptor antibodies |
| 01/28/2014 | CA2599734C Humanized l243 antibodies |
| 01/28/2014 | CA2540521C Anti-nik antibodies and uses thereof |
| 01/28/2014 | CA2534360C Methods for expression and purification of immunotoxins |
| 01/28/2014 | CA2520382C Lupus antibodies for passive immunotherapy of hiv/aids |
| 01/28/2014 | CA2510315C Antibodies against gpr64 and uses thereof |
| 01/28/2014 | CA2438884C Enzymes having alpha amylase activity and methods of use thereof |
| 01/28/2014 | CA2430039C Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 01/23/2014 | WO2014015280A1 Combination therapy of inhibitors for igf1 r and pi3k |
| 01/23/2014 | WO2014014897A2 Immunoglobulin-binding human mycoplasma antigens and methods of use thereof |
| 01/23/2014 | WO2014014796A1 Multi-specific igg-(fab)2 constructs containing t-cell receptor constant domains |
| 01/23/2014 | WO2014014207A1 Antibody for epitope tagging, hybridoma cell line and uses thereof |
| 01/23/2014 | WO2014014086A1 Cancer detection method |
| 01/23/2014 | WO2014013036A1 Inhibitors of the cd95 signaling pathway for treatment of mds |